Skip to main content
Powered by
buzzwords.news
(
US Patent 11,232,363 B2
) · created by
d-e-v.com
buzzwords.technology
main_menu
Home
Channels
Personalize
Headlines
Alexa Skill
Search
Search
Home
Headlines
The Next Phase of DeFi Is Here
posted:
Tue, 01/23/2024 - 13:07 EST
by:
CoinDesk Crypto
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqCryptocurrencies
,
#Cryptocurrencies
,
#Crypto
,
#CoinDesk
Putin, Sisi mark new phase of Egypt's Russian-built nuclear plant
posted:
Tue, 01/23/2024 - 10:03 EST
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
CD Projekt aims to start production phase of 'Polaris' in 2024
posted:
Mon, 01/22/2024 - 02:00 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Innovent Biologics : Phase 3 Trial Of Mazdutide In Obesity Meets Primary And Secondary Endpoints
posted:
Mon, 01/08/2024 - 22:49 EST
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Applied Therapeutics Announces Mixed Results From Phase 3 Trial Of AT-001 In Diabetic Cardiomyopathy
posted:
Thu, 01/04/2024 - 20:52 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Israel to pull some troops from Gaza as war enters new phase
posted:
Mon, 01/01/2024 - 04:38 EST
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Tesla Bull Raises Price Target for 2024 as Tesla Enters Next Phase of Growth
posted:
Tue, 12/26/2023 - 10:30 EST
by:
Nasdaq TSLA Tesla
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#TSLA
,
#Tesla
Argenx : Phase 3 Study Of Efgartigimod SC In Pemphigus Fails To Meet Primary & Secondary Endpoints
posted:
Wed, 12/20/2023 - 01:28 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
POLL-BOJ to phase out loose monetary policy in January, over 20% of economists say
posted:
Thu, 12/14/2023 - 23:05 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Vertex Announces Positive Results From Phase 2 Study Of VX-548 In Diabetic Peripheral Neuropathy
posted:
Wed, 12/13/2023 - 06:46 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Pharming To Develop Leniolisib For Additional PIDs Beyond APDS; Phase 2 Trial To Initiate In Q2
posted:
Wed, 12/13/2023 - 01:24 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Syndax Pharma Reveals Positive Data From Phase 1 Revumenib Combination Trials In Acute Leukemias
posted:
Mon, 12/11/2023 - 08:22 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Novartis: Phase III Study Shows Superiority Of Iptacopan In Patients With C3 Glomerulopathy
posted:
Mon, 12/11/2023 - 01:50 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
MorphoSys : Pelabresib Improves All Four Hallmarks Of Myelofibrosis In Phase 3 Study
posted:
Sun, 12/10/2023 - 23:43 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
AstraZeneca : Phase III Trial Data Show Danicopan Sustained Clinical Improvements In PNH
posted:
Sun, 12/10/2023 - 22:54 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Pagination
Previous page
‹‹
Page 5
Next page
››